Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Conference item |
Baskı/Yayın Bilgisi: |
American Thoracic Society
2017
|